, and cervical ectopic pregnancy [14] [15] [16] has been reported.
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Page Copy OBJECTIVE. The purpose of this study was to report on pregnancies and their outcome after uterine artery embolization for uterine fibroids.
SUBJECTS AND METHODS. From 2001 to 2004, 102 patients (mean age, [± SD]
35.7 ± 6.4 years; range, 20-48 years) with symptomatic uterine fibroids underwent uterine artery embolization with 500-to 710-µm polyvinyl alcohol particles. The mean uterine volume was 552 ± 649 cm 3 (range, 94-4,656 cm 3 ), and the dominant fibroid size was 228 ± 359 cm 3 (range, 14-2,618 cm 3 ) before the procedure. During the 2-year follow-up period, the patients were asked whether they were trying to achieve pregnancy and whether they were successful. We obtained pregnancy and obstetric records of the pregnant women from physicians' offices and hospitals.
RESULTS. Among 102 women who underwent bilateral uterine artery embolization, 23 (22.5%) were seeking to become pregnant, and 14 of the 23 (61%) became pregnant, nine having been nulliparous. One patient had two pregnancies. Fourteen pregnancies were spontaneous, and one was achieved by zygote intrafallopian transfer. Two miscarriages occurred, one in the 12th and one in the 16th week of gestation. The other 13 pregnancies went to term, were uncomplicated, and ended in elective cesarean delivery. All of the neonates were healthy with Apgar scores greater than 8. The mean weight of the neonates was 3,274 ± 514.4 g (range, 2,100-3,950 g). One neonate was small for gestational age (2,100 g).
CONCLUSION. Uterine artery embolization can serve as a substitute for invasive operations such as hysterectomy and myomectomy. Additional studies, including prospective, randomized comparisons with myomectomy, should be performed to ascertain whether uterine artery embolization is a safe procedure for women who want to preserve their fertility. before the procedure. Women desiring pregnancy were informed of the uncertain effect of embolization on fertility and pregnancy. At least a 6-month interval after embolization and before conception has been recommended [29] depending on fibroid shrinkage and uterine wound healing. We advised patients who wanted to conceive after embolization to wait 1 year. The settings of the angiographic system (GE DEX DSA, GE Healthcare) were 1,200 mA and 140 kVp. All patients underwent catheterization through a right femoral approach with a 4-or 5-French cobra-shaped catheter without microcatheters. Aortography was performed with a pigtail catheter before pelvic arteriography. The catheter was placed in the abdominal aorta at the level of the renal arteries, and selective catheterization of the uterine arteries was performed as follows.
The tip of a 4-or 5-French cobra-shaped catheter was positioned beyond the junction of the descending and horizontal portions of each uterine artery. Embolization was performed with 500-to 710-µm polyvinyl alcohol particles (Contour, Boston Scientific) injected manually under fluoroscopic control. The particles were slowly injected through the catheter. To avoid retrograde reflux of particles and infiltration to other internal iliac artery side branches, the injection was stopped when arterial flow ceased. When an anastomosis was encountered between the uterine and ovarian arteries, the catheter tip was placed in a position distal to the anastomosis. In some cases, we used gelatin foam particles to occlude the anastomosis temporarily and then performed UAE. We made the gelatin foam particles from sponge sheets (Gelitaspon, Gelita Medical) by cutting the sheet into small fragments with scissors. Postembolization angiography was performed for evaluation of redistribution.
Patients participated in follow-up conducted with questionnaires, telephone interviews, and sonography (EUB-525 system, Hitachi) 1, 3, 6, 12, and 24 months after UAE. At follow-up interviews, patients were asked whether they had been trying to achieve pregnancy and whether they had been successful. We obtained pregnancy and obstetric records of pregnant women from physician's offices and hospitals. Neonatal outcome measurements included gestational age (preterm < 37 weeks), sex, birthweight, and Apgar score. Low birthweight was defined as less than 2,500 g, and very low birthweight was defined as less than 1,500 g.
Results
Among 102 women who underwent bilateral UAE at our center, 23 (22.5%) intended to become pregnant, and 14 of the 23 (61%) became pregnant (Table 1) . In one patient, conception occurred twice within 12 months (pregnancies 6 and 7). One woman had an unintentional pregnancy.
The mean age at embolization was 31.2 ± 5.5 years (range, 23-40 years). Nine patients (64%) had been nulliparous. Four patients (28.5%) had a history of spontaneous abortion. Three patients (21%) had undergone myomectomy. The mean uterine volume before UAE in the patients who became pregnant was 536 ± 334 cm 3 (range, 161-1,087 cm 3 ), and the mean fibroid volume was 228 ± 252 cm 3 (range, 23.1-723 cm 3 ). The mean reduction in uterine volume after 1 year was approximately 37.8% ± 24.6%, and the mean reduction in fibroid volume after 1 year was 64.1% ± 43.1% in the patients who became pregnant. One patient had a history of infertility with fibroid as the main cause.
Thirteen pregnancies were spontaneous; pregnancy 5 was the result of successful zygote intrafallopian transfer. The mean age at conception was 33.8 ± 5.2 years (range, 27-41 years. The mean time from embolization to conception was 30.5 ± 14.5 months (range, 2-54 months). There were 13 elective cesarean deliveries; two miscarriages (13%) occurred, one at 12 weeks and the other at 16 One case of postpartum hemorrhage was caused by retained placental tissue. All neonates were born at term and were healthy, with Apgar scores higher than 8. The mean weight of the neonates was 3,274 ± 514.4 g (range, 2,100-3,950 g). One neonate was small for gestational age (2,100 g). The pregnancy and neonatal outcomes are summarized in Table 2 . None of the neonates was below the third percentile for weight.
Discussion
UAE has been found effective in the management of symptomatic uterine fibroids. Spies et al. [30] reported 90% resolution of heavy bleeding (95% CI, 86-95%) and 91% improvement in bulk-related symptoms (95% CI, 86-95%) at 1 year. In an earlier study [31] , we found resolution of menstrual bleeding in 81.8% of the patients and relief of bulk-related symptoms in 84.6%.
The gonads are one of the organs most sensitive to radiation and are in the direct path of the beam during embolization. Nonetheless, the radiation exposure appears to be comparable with that of routine diagnostic imaging procedures [32] . In one study [33] , 10 pregnancies occurred in 25 patients after embolization therapy for postpartum hemorrhage. Those authors concluded that women who undergo arterial embolization for obstetric hemorrhage can preserve their fertility and have successful uneventful pregnancies. McLucas et al. [23] evaluated 400 women who underwent UAE from 1996 to 1999. They found that among 139 patients who stated a desire for fertility after UAE, 14 women had 17 pregnancies.
Advanced maternal age adversely affects ovarian function, decreasing the number of good-quality oocytes and resulting in chromosomally abnormal conceptions that rarely develop further. Transient or permanent amenorrhea and other symptoms of ovarian failure have been found in more than 5% of women who have undergone UAE, especially women older than 45 years [34] [35] [36] . However, there have been reports of ovarian failure in younger women [35, 37] . Ovarian ischemia and loss of ovarian follicles due to nontarget embolization of ovaries are the most likely causes [38, 39] . Spies et al. [34] used serial basal follicle-stimulating hormone assays to evaluate change in ovarian function in 63 patients who had undergone UAE. Those investigators concluded that most of their patients had no change in ovarian function after UAE and that patients 45 years old or older have an approximately 15% chance of an increase in basal follicle-stimulating hormone level into the perimenopausal range. Results of a prospective study [40] in which the subjects were 20 regularly cycling women indicated no change in ovarian reserve as assessed with basal follicle-stimulating hormone and estradiol levels and ultrasound-based ovarian volume and antral follicle count as long as 12 months after UAE.
In our study, overall pregnancy complications were within the normal ranges of the general obstetric population. All infants in our study were born alive, and none was born preterm. One infant (pregnancy 12) had a low birthweight, and we did not find the exact cause of the low birthweight. The time between embolization and conception, 2 months in this case, may have been too short. This amount of time is not enough for complete involution of fibroids or for development of a collateral arterial supply. Patients who wanted to conceive after embolization were advised to wait 1 year, but this patient did not follow our advice. The optimal time to achieve pregnancy after embolization is unclear. A waiting period of 6 months after UAE and before conception, depending on fibroid shrinkage and the progress of uterine wound healing, has been recommended [29] .
Fibroids shrink slowly in most cases; most reductions occur within 6 months to 1 year after UAE. The extent and duration of uterine healing associated with these changes are unknown [23] . Reduction in uterine blood flow caused by bilateral UAE usually is reversed by collateral arterial circulation. In previous studies [41, 42] ultrasound imaging and MRI have shown revascularization of the normal myometrium 3-6 months after UAE.
Goldberg et al. [25] compared data on 53 pregnancies after uterine embolization and 139 pregnancies after laparoscopic myomectomy. They found that women who underwent UAE were older and higher in parity and had larger fibroids than women treated with myomectomy (p < 0.001). They concluded that women who underwent UAE were at higher risk of spontaneous abortion, postpartum hemorrhage, caesarean delivery, and giving birth to small-for-gestational age infants.
The Royal College of Obstetrics and Gynecology cites a 10-15% risk of spontaneous miscarriage in the general population, and rates of miscarriage increase twofold to threefold after the age of 40 years [43] . In the Ontario UAE trial, which is the most comprehensive report of pregnancy after UAE with polyvinyl alcohol particles (among 555 women, 22 conceived; three twice, for a total of 25 pregnancies), miscarriages occurred in four women (16.7%) [24] . The rate of miscarriage in our patients was 13% (two cases), and both patients were 41 years old. The spontaneous abortion rate, although based on a small sample population, does not seem to be greater than the rate in the general population. Residual fibroids after UAE can distort the shape of the uterine cavity and cause malimplantation. This complication can increase the rate of preterm birth and malpresentation, both of which are associated with UAE. The effects of embolization on the stretching ability of the myometrium and mechanisms that initiate labor also can have considerable influence on preterm labor.
In all cases in this study, elective cesarean delivery was performed because of the obstetricians' limited information on pregnancy after UAE. The result was a conservative approach to the management of labor for these patients. Goldberg et al. [25] reported a 63% rate of cesarean delivery in the UAE group and a rate of 59% in the laparoscopic myomectomy group. Walker and McDowell [26] reported 56 completed pregnancies in approximately 1,200 UAE patients; 33 pregnancies had successful outcomes, six infants were premature, and 17 pregnancies ended in miscarriage. Among the 33 deliveries, 24 (72.7%) were cesarean. The authors concluded that compared with the general obstetric population, women who undergo UAE have a significantly greater rate of cesarean delivery.
Advanced maternal age, multiparity, smoking, and previous cesarean delivery are known risks of abnormal placentation [24] . We do not have information about the placentas in our patients. Prenatal ultrasound examinations, however, did not show placental abnormalities. The literature is insufficient for gaining an understanding of the effects of UAE on placental function and fetal growth.
We conclude that UAE can serve as a substitute for invasive operations such as hysterectomy and myomectomy. Additional studies, including prospective randomized comparisons with myomectomy, should be performed to further test the safety and efficacy of UAE in the treatment of women with fibroids who want to preserve their fertility.
